Results 121 to 130 of about 104,562 (257)

A pro‐inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation

open access: yesBritish Journal of Haematology, EarlyView.
Primary antiphospholipid syndrome comprises distinct inflammatory subgroups defined by cytokine profiling. A shared pro‐inflammatory signature is present across all patients, whereas arterial thrombosis demonstrates enhanced inflammatory activation compared with venous thrombosis, suggesting divergent pathogenic mechanisms and opportunities for ...
Catherine B. Ducker   +6 more
wiley   +1 more source

Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients

open access: yesResearch in Molecular Medicine, 2016
Background: Warfarin is a common anticoagulant drug that has a narrow therapeutic index; higher dose causes excessive bleeding and lower dose leads to cerebrovascular clotting and stroke in patients.
Reyhaneh Kameli   +7 more
doaj  

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices

open access: yes, 2012
Edward Ewen,1 Zugui Zhang,1 Teresa A Simon,2 Paul Kolm,1 Xianchen Liu,3,4 William S Weintraub11Christiana Care Health System, Newark, DE, USA; 2Bristol-Myers Squibb, Princeton, NJ, USA; 3Indiana University School of Medicine, Indianapolis, IN, USA ...
Liu X   +5 more
core  

Quantitative fluorescence of warfarin-HSA binding interaction.

open access: yes, 2014
a: Each experiment was performed in triplicate.b: Warfarin was not added.Quantitative fluorescence of warfarin-HSA binding interaction.
Yan-Shan Huang (678698)   +5 more
core   +1 more source

Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study

open access: yesBJU International, EarlyView.
Objective Our objective was to evaluate the safety and effectiveness of Aquablation® as a salvage therapy in patients who underwent prior intervention for benign prostatic hyperplasia (BPH). Materials and Methods We retrospectively analysed 1887 consecutive men from the International Collaborative Aquablation Research Urology Society database between ...
Anouk Leathead   +24 more
wiley   +1 more source

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients

open access: yes, 2018
 Jubby Marcela Galvez,1 Carlos Martin Restrepo,1 Nora Constanza Contreras,1 Clara Alvarado,1 Carlos-Alberto Calderón-Ospina,1 Nidia Peña,1 Ricardo A Cifuentes,2 Daniela Duarte,1 Paul Laissue,1 Dora Janeth Fonseca1 1GENIUROS Research ...
Peña N   +9 more
core  

Knowledge of warfarin therapy among patients attending Warfarin Clinic at a Public Hospital in Northern part of Malaysian Peninsular

open access: yes, 2016
Background: Patient′s knowledge of anticoagulation therapy is important to achieving and maintaining optimal therapy outcome as well as reducing adverse events.
Amal K Suleiman   +4 more
core   +1 more source

Voice Fundamental Frequency Variation and Statin Therapy

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objectives Statins are considered a first‐line treatment for dyslipidaemia, being the most frequently prescribed medicine worldwide. However, statin therapy has been associated with several adverse effects, including statin‐associated myopathy, which may manifest with symptoms such as myalgia, muscle stiffness, and cramps.
Luca Francesco Parata   +5 more
wiley   +1 more source

Correlation between Metabolic Parameters and Warfarin Dose in Patients with Heart Valve Replacement of Different Genotypes

open access: yesReviews in Cardiovascular Medicine
Background: Warfarin has become the first choice for anticoagulation in patients who need lifelong anticoagulation due to its clinical efficacy and low price.
Xiaowu Wang   +4 more
doaj   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy